carnitine has been researched along with Diabetic Neuropathies in 17 studies
Diabetic Neuropathies: Peripheral, autonomic, and cranial nerve disorders that are associated with DIABETES MELLITUS. These conditions usually result from diabetic microvascular injury involving small blood vessels that supply nerves (VASA NERVORUM). Relatively common conditions which may be associated with diabetic neuropathy include third nerve palsy (see OCULOMOTOR NERVE DISEASES); MONONEUROPATHY; mononeuropathy multiplex; diabetic amyotrophy; a painful POLYNEUROPATHY; autonomic neuropathy; and thoracoabdominal neuropathy. (From Adams et al., Principles of Neurology, 6th ed, p1325)
Excerpt | Relevance | Reference |
---|---|---|
"A total of 1,035 patients with NIDDM and IDDM were included." | 2.69 | Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration. ( Abbott, CA; Boulton, AJ; Carrington, AL; Vileikyte, L; Williamson, S, 1998) |
"In participants with type 2 diabetes, after Bonferroni correction and rigorous adjustment, SDNN was inversely associated with higher levels of diacyl-phosphatidylcholine (PCaa) C32:0, PCaa C34:1, acyl-alkyl-phosphatidylcholine (PCae) C36:0, SM C16:0 and SM C16:1." | 1.62 | Association of cardiac autonomic dysfunction with higher levels of plasma lipid metabolites in recent-onset type 2 diabetes. ( Bönhof, GJ; Knebel, B; Kotzka, J; Roden, M; Straßburger, K; Strom, A; Szendroedi, J; Ziegler, D, 2021) |
"L‑carnitine (LC) was recently demonstrated to serve a positive role in ameliorating DPN." | 1.51 | L-carnitine ameliorates peripheral neuropathy in diabetic mice with a corresponding increase in insulin‑like growth factor‑1 level. ( Dong, J; Liu, Y; Ma, R; Song, L; Wang, L; Wang, R; Zhang, C; Zhang, Y, 2019) |
"Alloxan treatment caused hyperglycemia and reduced boy growth." | 1.29 | Diabetic neuropathy in the rat: 1. Alcar augments the reduced levels and axoplasmic transport of substance P. ( Di Giulio, AM; Gorio, A; Lesma, E, 1995) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (5.88) | 18.7374 |
1990's | 11 (64.71) | 18.2507 |
2000's | 1 (5.88) | 29.6817 |
2010's | 2 (11.76) | 24.3611 |
2020's | 2 (11.76) | 2.80 |
Authors | Studies |
---|---|
Ziegler, D | 1 |
Strom, A | 1 |
Straßburger, K | 1 |
Knebel, B | 1 |
Bönhof, GJ | 1 |
Kotzka, J | 1 |
Szendroedi, J | 1 |
Roden, M | 1 |
Didangelos, T | 1 |
Karlafti, E | 1 |
Kotzakioulafi, E | 1 |
Kontoninas, Z | 1 |
Margaritidis, C | 1 |
Giannoulaki, P | 1 |
Kantartzis, K | 1 |
Wang, R | 1 |
Wang, L | 1 |
Zhang, C | 1 |
Zhang, Y | 1 |
Liu, Y | 1 |
Song, L | 1 |
Ma, R | 1 |
Dong, J | 1 |
Freeman, OJ | 1 |
Unwin, RD | 1 |
Dowsey, AW | 1 |
Begley, P | 1 |
Ali, S | 1 |
Hollywood, KA | 1 |
Rustogi, N | 1 |
Petersen, RS | 1 |
Dunn, WB | 1 |
Cooper, GJ | 1 |
Gardiner, NJ | 1 |
Poorabbas, A | 1 |
Fallah, F | 1 |
Bagdadchi, J | 1 |
Mahdavi, R | 1 |
Aliasgarzadeh, A | 1 |
Asadi, Y | 1 |
Koushavar, H | 1 |
Vahed Jabbari, M | 1 |
Di Giulio, AM | 1 |
Lesma, E | 1 |
Gorio, A | 1 |
Stevens, MJ | 1 |
Feldman, EL | 1 |
Greene, DA | 1 |
Ido, Y | 1 |
McHowat, J | 1 |
Chang, KC | 1 |
Arrigoni-Martelli, E | 1 |
Orfalian, Z | 1 |
Kilo, C | 1 |
Corr, PB | 1 |
Williamson, JR | 1 |
Hotta, N | 2 |
Koh, N | 2 |
Sakakibara, F | 2 |
Nakamura, J | 2 |
Hamada, Y | 2 |
Wakao, T | 1 |
Hara, T | 2 |
Mori, K | 1 |
Naruse, K | 2 |
Nakashima, E | 2 |
Sakamoto, N | 1 |
Arduini, A | 2 |
Chiodi, P | 2 |
Bellucci, A | 1 |
Calvani, M | 1 |
Yildiz, O | 2 |
Ozata, M | 2 |
Ozkardeş, A | 2 |
Deniz, G | 1 |
Yildirimkaya, M | 1 |
Corakçi, A | 2 |
Yardim, M | 1 |
Gündoğan, MA | 2 |
Gündoğan, N | 1 |
Cameron, NE | 1 |
Cotter, MA | 1 |
Abbott, CA | 1 |
Vileikyte, L | 1 |
Williamson, S | 1 |
Carrington, AL | 1 |
Boulton, AJ | 1 |
Sasaki, H | 1 |
Chaya, S | 1 |
Komori, T | 1 |
Kato, K | 1 |
Takeuchi, N | 1 |
Kasuya, Y | 1 |
Scarpini, E | 1 |
Doneda, P | 1 |
Pizzul, S | 1 |
Ramacci, MT | 1 |
Baron, P | 1 |
Conti, G | 1 |
Sacilotto, G | 1 |
Scarlato, G | 1 |
Tahiliani, AG | 1 |
McNeill, JH | 1 |
2 reviews available for carnitine and Diabetic Neuropathies
Article | Year |
---|---|
The aetiology of diabetic neuropathy: the combined roles of metabolic and vascular defects.
Topics: Aldehyde Reductase; Animals; Carnitine; Cells; Diabetes Mellitus; Diabetes Mellitus, Experimental; D | 1995 |
Diabetes-induced abnormalities in the myocardium.
Topics: Adenosine Triphosphatases; Animals; Blood Glucose; Calcium; Carbohydrate Metabolism; Cardiomyopathie | 1986 |
2 trials available for carnitine and Diabetic Neuropathies
Article | Year |
---|---|
Efficacy and Safety of the Combination of Superoxide Dismutase, Alpha Lipoic Acid, Vitamin B12, and Carnitine for 12 Months in Patients with Diabetic Neuropathy.
Topics: Aged; Carnitine; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Double-Blind Method; Drug Combina | 2020 |
Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration.
Topics: Adult; Aged; Canada; Carnitine; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Foot; | 1998 |
13 other studies available for carnitine and Diabetic Neuropathies
Article | Year |
---|---|
Association of cardiac autonomic dysfunction with higher levels of plasma lipid metabolites in recent-onset type 2 diabetes.
Topics: Adult; Autonomic Nervous System Diseases; Carnitine; Diabetes Mellitus, Type 1; Diabetes Mellitus, T | 2021 |
L-carnitine ameliorates peripheral neuropathy in diabetic mice with a corresponding increase in insulin‑like growth factor‑1 level.
Topics: Animals; Blood Glucose; Carnitine; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Insulin-L | 2019 |
Metabolic Dysfunction Is Restricted to the Sciatic Nerve in Experimental Diabetic Neuropathy.
Topics: Animals; Carnitine; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Models, Animal; | 2016 |
Determination of free L-carnitine levels in type II diabetic women with and without complications.
Topics: Blood Glucose; Blood Pressure; Body Mass Index; Carnitine; Case-Control Studies; Cross-Sectional Stu | 2007 |
Diabetic neuropathy in the rat: 1. Alcar augments the reduced levels and axoplasmic transport of substance P.
Topics: Alloxan; Animals; Axons; Blood Glucose; Body Weight; Carnitine; Diabetic Neuropathies; Male; Rats; R | 1995 |
Neural dysfunction and metabolic imbalances in diabetic rats. Prevention by acetyl-L-carnitine.
Topics: Acetylcarnitine; Animals; Ca(2+) Mg(2+)-ATPase; Carnitine; Diabetes Mellitus, Experimental; Diabetic | 1994 |
Effect of propionyl-L-carnitine on motor nerve conduction, autonomic cardiac function, and nerve blood flow in rats with streptozotocin-induced diabetes: comparison with an aldose reductase inhibitor.
Topics: Aldehyde Reductase; Animals; Blood Glucose; Body Weight; Carbohydrate Metabolism; Cardiotonic Agents | 1996 |
Abnormality of nerve conduction in diabetic neuropathy: Is there a functional relationship with the carnitine system?
Topics: Animals; Carnitine; Diabetic Neuropathies; Male; Neural Conduction; Rats; Rats, Sprague-Dawley; Scia | 1996 |
Comparison of the effects of aminoguanidine and L-carnitine treatments on somatosensorial evoked potentials in alloxan-diabetic rats.
Topics: Alloxan; Animals; Blood Glucose; Body Weight; Carnitine; Diabetes Mellitus, Experimental; Diabetic N | 1996 |
L-carnitine treatment improves brain stem auditory evoked potentials in diabetic rats.
Topics: Animals; Blood Glucose; Body Weight; Carnitine; Diabetes Mellitus, Experimental; Diabetic Neuropathi | 1996 |
Metabolic and vascular factors in the pathogenesis of diabetic neuropathy.
Topics: Animals; Carnitine; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Endothelium, Vascular; F | 1997 |
Polyol pathway hyperactivity is closely related to carnitine deficiency in the pathogenesis of diabetic neuropathy of streptozotocin-diabetic rats.
Topics: Acetylcarnitine; Aldehyde Reductase; Animals; Body Weight; Carnitine; Diabetes Mellitus, Experimenta | 1998 |
L-carnitine and acetyl-L-carnitine in human nerves from normal and diabetic subjects.
Topics: Acetylcarnitine; Adult; Aged; Aged, 80 and over; Carnitine; Diabetic Neuropathies; Female; Humans; I | 1996 |